Rodney D. Altman, M.D.
Senior Partner
CMEAVentures
Omar Amirana, M.D.
Investment Manager
Oxford Bioscience Partners
David R. Dantzker, M.D.
General Partner
Wheatley Partners
Stephen Knight, M.D.
Managing Partner
Fidelity BioSciences
Leonide Saad, Ph.D.
Vice President
Proteus Venture Partners
Lauren Silverman, Ph.D.
Managing Director
Novartis BioVentures
Tracy Warren
General Partner
Battelle Ventures
| |
| 9:50 am |
BREAK |
| |
|
| 10:00
am |
COMPANY
PRESENTATIONS – ROUND I
|
| |
|
| 11:00
am |
NETWORKING & REFRESHMENT BREAK |
| |
|
| 11:40 am |
COMPANY
PRESENTATIONS – ROUND II
|
| |
|
| 12:40 pm |
LUNCH & NETWORKING |
| |
|
| 1:40
pm |
COMPANY
PRESENTATIONS – ROUND III
|
| |
|
2:40 pm
|
VC CHECKUP
Case studies, VCs compare and contrast the growth of seemingly healthy companies. What did these companies do right? Where did they go wrong? Which one would be considered a healthier investment and why? Does your company measure up? What healthy habits will make your company a more desirable investment? Growing into a revenue generating company takes more than money. Find out if you pass the VC check up.
Moderator:
Thomas C. Meyers
Partner
Cooley Godward Kronish
Panelists:
Anup Arora
Vice President
Easton Capital
Jens W. Eckstein
General Partner
TVM Capital
David F. Hendren
General Partner
Catalyst Health Ventures
Arthur Klausner, MBA
Partner
Pappas Ventures
Derek Lee
Principal
SV Life Sciences
James E. Thomas
Managing Partner
Thomas, McNerney & Partners
Arthur Tinkelenberg, Ph.D.
Partner
Ascent Biomedical Ventures
|